Insmed IncorporatedINSMNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
4.79%
↓ 84% below average
Average (9y)
29.19%
Historical baseline
Range
High:65.22%
Low:-10.57%
CAGR
-19.0%
Structural decline
| Period | Value |
|---|---|
| 2024 | 4.79% |
| 2023 | 43.64% |
| 2022 | 45.75% |
| 2021 | 50.56% |
| 2020 | 37.54% |
| 2019 | -9.34% |
| 2018 | 32.38% |
| 2017 | -10.57% |
| 2016 | 65.22% |
| 2015 | 31.95% |